Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
glucocerebrosidase | 2 | 0 | 0 | 2 |
DNA polymerase kappa isoform 1 | 3 | 0 | 0 | 3 |
histone acetyltransferase KAT2A isoform 1 | 5 | 0 | 0 | 5 |
Atrial natriuretic peptide receptor 3 | 0 | 1 | 0 | 1 |
Type-1A angiotensin II receptor | 0 | 2 | 1 | 3 |
Type-1 angiotensin II receptor | 0 | 0 | 1 | 1 |
Type-1B angiotensin II receptor | 0 | 2 | 0 | 2 |
Type-1 angiotensin II receptor | 0 | 2 | 2 | 4 |
Type-2 angiotensin II receptor | 0 | 2 | 0 | 2 |
Type-2 angiotensin II receptor | 0 | 2 | 0 | 2 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 4 | 0 | 0 | 4 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 2 | 2 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 2 | 2 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 2 | 2 |
thioredoxin reductase | 4 | 0 | 0 | 4 |
phosphopantetheinyl transferase | 3 | 0 | 0 | 3 |
NFKB1 protein, partial | 2 | 0 | 0 | 2 |
GLS protein | 4 | 0 | 0 | 4 |
thyroid stimulating hormone receptor | 3 | 0 | 0 | 3 |
alpha-galactosidase | 2 | 0 | 0 | 2 |
euchromatic histone-lysine N-methyltransferase 2 | 6 | 0 | 0 | 6 |
cytochrome P450 2C19 precursor | 3 | 0 | 0 | 3 |
chromobox protein homolog 1 | 2 | 0 | 0 | 2 |
flap endonuclease 1 | 5 | 0 | 0 | 5 |
DNA polymerase iota isoform a (long) | 2 | 0 | 0 | 2 |
muscarinic acetylcholine receptor M1 | 2 | 0 | 0 | 2 |
lethal factor (plasmid) | 1 | 0 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 6 | 1 | 9 |
Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 0 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 0 | 1 | 3 |
Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
ATP-dependent phosphofructokinase | 3 | 0 | 0 | 3 |
Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
Bile salt export pump | 0 | 9 | 0 | 9 |
Solute carrier family 22 member 16 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 21 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
USP1 protein, partial | 6 | 0 | 0 | 6 |
TDP1 protein | 9 | 0 | 0 | 9 |
Microtubule-associated protein tau | 4 | 0 | 0 | 4 |
glucocorticoid receptor [Homo sapiens] | 9 | 0 | 0 | 9 |
peroxisome proliferator-activated receptor delta | 6 | 0 | 0 | 6 |
cytochrome P450 2D6 isoform 1 | 2 | 0 | 0 | 2 |
thyroid hormone receptor beta isoform a | 3 | 0 | 0 | 3 |
cytochrome P450 3A4 isoform 1 | 4 | 0 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit pi | 4 | 0 | 0 | 4 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 0 | 2 | 2 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 0 | 2 | 2 |
Fatty acid-binding protein, intestinal | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 4 | 0 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit delta | 4 | 0 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 4 | 0 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 4 | 0 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 4 | 0 | 0 | 4 |
Peroxisome proliferator-activated receptor alpha | 0 | 2 | 2 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 4 | 0 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 4 | 0 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 4 | 0 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 4 | 0 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 4 | 0 | 0 | 4 |
Peroxisome proliferator-activated receptor gamma | 0 | 7 | 7 | 17 |
Peroxisome proliferator-activated receptor gamma | 0 | 1 | 4 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 4 | 0 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit beta-3 | 4 | 0 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit beta-2 | 4 | 0 | 0 | 4 |
Peroxisome proliferator-activated receptor delta | 0 | 2 | 2 | 4 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 0 | 2 | 2 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 0 | 1 | 1 |
Peroxisome proliferator-activated receptor alpha | 1 | 3 | 4 | 9 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 0 | 2 | 2 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 0 | 2 | 2 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 0 | 2 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 0 | 2 | 2 |
GABA theta subunit | 4 | 0 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit epsilon | 4 | 0 | 0 | 4 |
Chain A, Glutamine Binding Protein | 0 | 0 | 1 | 1 |
15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
arylsulfatase A | 3 | 0 | 0 | 3 |
Bloom syndrome protein isoform 1 | 2 | 0 | 0 | 2 |
peripheral myelin protein 22 isoform 1 | 3 | 0 | 0 | 3 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 2 | 0 | 0 | 2 |
Carbonic anhydrase 1 | 0 | 0 | 0 | 4 |
Carbonic anhydrase 2 | 0 | 3 | 0 | 7 |
Neutral amino acid transporter A | 0 | 1 | 0 | 1 |
Asc-type amino acid transporter 1 | 0 | 1 | 0 | 1 |
Neutral amino acid transporter B(0) | 0 | 1 | 0 | 1 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 3 |
Amino acid transporter | 0 | 1 | 0 | 1 |
Chain A, Ferritin light chain | 4 | 0 | 0 | 4 |
Luciferase | 3 | 0 | 0 | 3 |
Nrf2 | 1 | 0 | 0 | 1 |
SMAD family member 2 | 4 | 0 | 0 | 4 |
ATAD5 protein, partial | 2 | 0 | 0 | 2 |
SMAD family member 3 | 4 | 0 | 0 | 4 |
GLI family zinc finger 3 | 6 | 0 | 0 | 6 |
Thrombopoietin | 1 | 0 | 0 | 1 |
AR protein | 7 | 0 | 0 | 7 |
estrogen receptor 2 (ER beta) | 4 | 0 | 0 | 4 |
nuclear receptor subfamily 1, group I, member 3 | 4 | 0 | 0 | 4 |
retinoic acid nuclear receptor alpha variant 1 | 6 | 0 | 0 | 6 |
retinoid X nuclear receptor alpha | 4 | 0 | 0 | 4 |
estrogen-related nuclear receptor alpha | 7 | 0 | 0 | 7 |
pregnane X nuclear receptor | 4 | 0 | 0 | 4 |
estrogen nuclear receptor alpha | 8 | 0 | 0 | 8 |
bromodomain adjacent to zinc finger domain 2B | 3 | 0 | 0 | 3 |
peroxisome proliferator activated receptor gamma | 7 | 0 | 0 | 7 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 3 | 0 | 0 | 3 |
pyruvate kinase | 1 | 0 | 0 | 1 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
aryl hydrocarbon receptor | 2 | 0 | 0 | 2 |
neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform 2 | 7 | 0 | 0 | 7 |
heat shock protein beta-1 | 2 | 0 | 0 | 2 |
mitogen-activated protein kinase 1 | 1 | 0 | 0 | 1 |
serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 5 | 0 | 0 | 5 |
geminin | 8 | 0 | 0 | 8 |
survival motor neuron protein isoform d | 1 | 0 | 0 | 1 |
M-phase phosphoprotein 8 | 2 | 0 | 0 | 2 |
muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 4 | 0 | 0 | 4 |
pyruvate kinase PKM isoform b | 1 | 0 | 0 | 1 |
Voltage-dependent calcium channel gamma-2 subunit | 4 | 0 | 0 | 4 |
Cellular tumor antigen p53 | 7 | 0 | 0 | 7 |
Integrin beta-3 | 1 | 0 | 0 | 1 |
Integrin alpha-IIb | 1 | 0 | 0 | 1 |
Ornithine decarboxylase | 1 | 0 | 0 | 1 |
Glutamate receptor 2 | 4 | 0 | 0 | 4 |
Histamine H2 receptor | 2 | 0 | 0 | 2 |
Nuclear receptor ROR-gamma | 0 | 1 | 0 | 1 |
Chain A, HISTIDINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Carbonic anhydrase 12 | 0 | 0 | 0 | 2 |
Plasma kallikrein | 0 | 0 | 0 | 2 |
Carbonic anhydrase 3 | 0 | 0 | 0 | 2 |
Histidine-binding periplasmic protein | 0 | 0 | 1 | 1 |
Carbonic anhydrase 4 | 0 | 0 | 0 | 2 |
Carbonic anhydrase 6 | 0 | 0 | 0 | 2 |
Adenosine receptor A1 | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 1 |
Adenosine receptor A2a | 0 | 0 | 0 | 1 |
Carbonic anhydrase 5A, mitochondrial | 0 | 0 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 0 | 1 | 3 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Carbonic anhydrase 7 | 0 | 0 | 0 | 2 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 0 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 0 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 0 | 0 | 2 |
Large neutral amino acids transporter small subunit 1 | 0 | 3 | 0 | 3 |
Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 0 | 0 | 2 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 0 | 0 | 2 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 0 | 0 | 2 |
Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 15 | 0 | 0 | 0 | 2 |
Carbonic anhydrase 13 | 0 | 0 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 0 | 0 | 2 |
Carbonic anhydrase 14 | 0 | 0 | 0 | 2 |
Carbonic anhydrase 5B, mitochondrial | 0 | 0 | 0 | 2 |
Chain A, PROTEIN (PROTEASE) | 0 | 1 | 0 | 1 |
Chain B, PROTEIN (PROTEASE) | 0 | 1 | 0 | 1 |
Chain A, PROTEIN (PROTEASE) | 0 | 1 | 0 | 1 |
Chain B, PROTEIN (PROTEASE) | 0 | 1 | 0 | 1 |
Chain A, HIV-1 PROTEASE | 0 | 1 | 0 | 1 |
Chain B, HIV-1 PROTEASE | 0 | 1 | 0 | 1 |
Chain A, HIV-II PROTEASE | 0 | 1 | 0 | 1 |
Chain B, HIV-II PROTEASE | 0 | 1 | 0 | 1 |
Chain A, POL polyprotein | 0 | 0 | 1 | 1 |
Chain B, POL polyprotein | 0 | 0 | 1 | 1 |
Chain A, POL polyprotein | 0 | 0 | 1 | 1 |
Chain B, POL polyprotein | 0 | 0 | 1 | 1 |
Chain A, POL polyprotein | 0 | 0 | 1 | 1 |
Chain B, POL polyprotein | 0 | 0 | 1 | 1 |
Chain A, POL polyprotein | 0 | 0 | 1 | 1 |
Chain B, POL polyprotein | 0 | 0 | 1 | 1 |
Chain A, protease RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain B, protease RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain A, protease RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain B, protease RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain A, protease RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain B, protease RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain A, POL polyprotein | 0 | 1 | 0 | 1 |
Chain B, POL polyprotein | 0 | 1 | 0 | 1 |
Chain A, POL polyprotein | 0 | 1 | 0 | 1 |
Chain B, POL polyprotein | 0 | 1 | 0 | 1 |
Chain A, HIV-1 protease | 0 | 1 | 0 | 1 |
Chain B, HIV-1 protease | 0 | 1 | 0 | 1 |
Chain A, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain B, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain A, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain B, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain A, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain B, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain A, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain B, Pol polyprotein | 0 | 1 | 0 | 1 |
Chain A, Hiv-1 Protease | 0 | 1 | 0 | 1 |
Chain B, Hiv-1 Protease | 0 | 1 | 0 | 1 |
Chain A, Hiv-1 Protease | 0 | 1 | 0 | 1 |
Chain B, Hiv-1 Protease | 0 | 1 | 0 | 1 |
Chain A, Hiv-1 Protease | 0 | 1 | 0 | 1 |
Chain B, Hiv-1 Protease | 0 | 1 | 0 | 1 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 5 | 0 | 0 | 5 |
G | 3 | 0 | 0 | 3 |
cytochrome P450 2D6 | 3 | 0 | 0 | 3 |
Solute carrier family 22 member 2 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 1 | 0 | 2 | 0 | 2 |
ATP-binding cassette sub-family C member 3 | 0 | 8 | 0 | 8 |
Multidrug resistance-associated protein 4 | 0 | 8 | 0 | 8 |
Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
Interferon beta | 3 | 0 | 0 | 3 |
HLA class I histocompatibility antigen, B alpha chain | 3 | 0 | 0 | 3 |
Albumin | 0 | 0 | 0 | 6 |
Gag-Pol polyprotein | 0 | 4 | 0 | 4 |
Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
Gag-Pol polyprotein | 0 | 2 | 0 | 2 |
Gag polyprotein | 0 | 1 | 0 | 1 |
Gag-Pol polyprotein | 0 | 3 | 0 | 3 |
ATP-dependent translocase ABCB1 | 0 | 4 | 0 | 4 |
Replicase polyprotein 1ab | 0 | 3 | 1 | 4 |
Replicase polyprotein 1ab | 0 | 4 | 1 | 5 |
Cytochrome P450 2D6 | 0 | 1 | 0 | 1 |
Gag-Pol polyprotein | 0 | 3 | 0 | 3 |
Alpha-1B adrenergic receptor | 0 | 6 | 0 | 6 |
Substance-K receptor | 0 | 4 | 0 | 4 |
Alpha-1D adrenergic receptor | 0 | 3 | 0 | 3 |
Thromboxane-A synthase | 0 | 4 | 0 | 4 |
Gag-Pol polyprotein | 0 | 3 | 0 | 3 |
Alpha-1A adrenergic receptor | 0 | 6 | 0 | 6 |
Thromboxane-A synthase | 0 | 0 | 0 | 1 |
Genome polyprotein | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 2 | 0 | 3 |
Protease | 0 | 6 | 3 | 13 |
Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 3 | 0 | 0 | 3 |
Canalicular multispecific organic anion transporter 1 | 0 | 5 | 0 | 5 |
Multidrug and toxin extrusion protein 1 | 0 | 3 | 0 | 3 |
Protease | 0 | 6 | 4 | 11 |
Protease | 0 | 1 | 0 | 1 |
cytochrome P450 2C9, partial | 3 | 0 | 0 | 3 |
Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
Chain A, Leucine Aminopeptidase | 0 | 1 | 0 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
Intestinal-type alkaline phosphatase | 0 | 2 | 0 | 2 |
Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 2 |
Phospholipase A-2-activating protein | 0 | 2 | 0 | 2 |
Glucagon-like peptide 1 receptor | 0 | 2 | 2 | 4 |
Chain A, protease | 0 | 1 | 0 | 1 |
Chain B, protease | 0 | 1 | 0 | 1 |
Chain A, protease | 0 | 0 | 1 | 1 |
Chain B, protease | 0 | 0 | 1 | 1 |
Chain A, protease | 0 | 0 | 1 | 1 |
Chain B, protease | 0 | 0 | 1 | 1 |
Chain A, protease | 0 | 0 | 1 | 1 |
Chain B, protease | 0 | 0 | 1 | 1 |
Chain A, protease | 0 | 0 | 1 | 1 |
Chain B, protease | 0 | 0 | 1 | 1 |
Chain A, protease | 0 | 0 | 1 | 1 |
Chain B, protease | 0 | 0 | 1 | 1 |
Chain A, Protease | 0 | 1 | 0 | 1 |
Chain B, Protease | 0 | 1 | 0 | 1 |
Chain A, Protease | 0 | 1 | 0 | 1 |
Chain B, Protease | 0 | 1 | 0 | 1 |
Chain A, Protease | 0 | 1 | 0 | 1 |
Chain B, Protease | 0 | 1 | 0 | 1 |
Chain A, PROTEASE RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain B, PROTEASE RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain A, Protease Retropepsin | 0 | 1 | 0 | 1 |
Chain B, Protease Retropepsin | 0 | 1 | 0 | 1 |
Chain A, Protease Retropepsin | 0 | 1 | 0 | 1 |
Chain B, Protease Retropepsin | 0 | 1 | 0 | 1 |
RAR-related orphan receptor gamma | 4 | 0 | 0 | 4 |
Fumarate hydratase | 1 | 0 | 0 | 1 |
Smad3 | 3 | 0 | 0 | 3 |
progesterone receptor | 3 | 0 | 0 | 3 |
EWS/FLI fusion protein | 4 | 0 | 0 | 4 |
farnesoid X nuclear receptor | 4 | 0 | 0 | 4 |
polyprotein | 1 | 0 | 0 | 1 |
67.9K protein | 3 | 0 | 0 | 3 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 5 | 0 | 0 | 5 |
nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
Spike glycoprotein | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
potassium voltage-gated channel subfamily H member 2 isoform d | 1 | 0 | 0 | 1 |
nuclear receptor ROR-gamma isoform 1 | 4 | 0 | 0 | 4 |
peripheral myelin protein 22 | 5 | 0 | 0 | 5 |
Transmembrane protease serine 2 | 0 | 0 | 1 | 1 |
Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
Procathepsin L | 0 | 0 | 1 | 1 |
Replicase polyprotein 1a | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
Spike glycoprotein | 3 | 0 | 1 | 4 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 3 | 0 | 3 |
CAAX prenyl protease 1 homolog | 0 | 1 | 0 | 1 |
Plasmepsin V | 0 | 1 | 0 | 1 |
ATPase family AAA domain-containing protein 5 | 3 | 0 | 0 | 3 |
Ataxin-2 | 3 | 0 | 0 | 3 |
Angiotensin-converting enzyme 2 | 0 | 0 | 1 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 3 | 0 | 3 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 3 | 0 | 0 | 3 |
Dihydrofolate reductase | 0 | 3 | 0 | 3 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
Chain A, ASPARTYLPROTEASE | 0 | 1 | 0 | 1 |
Chain B, ASPARTYLPROTEASE | 0 | 1 | 0 | 1 |
glp-1 receptor, partial | 2 | 0 | 0 | 2 |
nonstructural protein 1 | 1 | 0 | 0 | 1 |
IDH1 | 2 | 0 | 0 | 2 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 1 | 0 | 0 | 1 |
DNA polymerase beta | 1 | 0 | 0 | 1 |
urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
plasminogen precursor | 1 | 0 | 0 | 1 |
urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
Adenosine receptor A3 | 0 | 4 | 0 | 4 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
Androgen receptor | 0 | 4 | 0 | 5 |
Potassium voltage-gated channel subfamily E member 1 | 0 | 1 | 0 | 1 |
Cytochrome P450 3A5 | 0 | 2 | 1 | 3 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
D(1A) dopamine receptor | 0 | 2 | 0 | 2 |
Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
Cruzipain | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 3 | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 2 | 0 | 2 |
Delta-type opioid receptor | 0 | 2 | 0 | 2 |
Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily KQT member 1 | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
TAR DNA-binding protein 43 | 1 | 0 | 0 | 1 |
Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 14 | 0 | 1 | 1 | 2 |
Potassium voltage-gated channel subfamily D member 3 | 0 | 1 | 0 | 1 |
Chain A, Fatty acid-binding protein, adipocyte | 0 | 1 | 0 | 1 |
acetylcholinesterase | 2 | 0 | 0 | 2 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Toll-like receptor 2 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, adipocyte | 0 | 2 | 1 | 3 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 4 | 0 | 4 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Fatty acid-binding protein 5 | 0 | 2 | 1 | 3 |
Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
Transient receptor potential cation channel subfamily V member 2 | 0 | 1 | 0 | 1 |
aldehyde dehydrogenase 1 family, member A1 | 1 | 0 | 0 | 1 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
tyrosine-protein kinase Yes | 1 | 0 | 0 | 1 |
Free fatty acid receptor 1 | 0 | 0 | 2 | 2 |
Bile salt export pump | 0 | 3 | 0 | 3 |
Peroxisome proliferator-activated receptor gamma | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 3 | 3 |
Muscarinic acetylcholine receptor M3 | 0 | 0 | 3 | 3 |
Muscarinic acetylcholine receptor M4 | 0 | 0 | 3 | 3 |
Steryl-sulfatase | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M5 | 0 | 0 | 3 | 3 |
Muscarinic acetylcholine receptor M2 | 0 | 0 | 3 | 3 |
Carnitine O-palmitoyltransferase 2, mitochondrial | 0 | 2 | 0 | 2 |
Amine oxidase [flavin-containing] B | 0 | 3 | 0 | 3 |
Amine oxidase [flavin-containing] A | 0 | 3 | 0 | 3 |
Amine oxidase [flavin-containing] A | 0 | 3 | 0 | 3 |
Carnitine O-palmitoyltransferase 2, mitochondrial | 0 | 2 | 0 | 2 |
Amine oxidase [flavin-containing] B | 0 | 6 | 0 | 6 |
Carnitine O-palmitoyltransferase 1, liver isoform | 0 | 2 | 0 | 2 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 1 |
CDGSH iron-sulfur domain-containing protein 2 | 0 | 2 | 0 | 2 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 4 | 0 | 4 |
Chain A, HADH2 protein | 1 | 0 | 0 | 1 |
Chain B, HADH2 protein | 1 | 0 | 0 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 2 | 0 | 0 | 2 |
thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 2 | 0 | 0 | 2 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 1 | 0 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 1 | 1 | 2 |
Catechol O-methyltransferase | 0 | 0 | 1 | 1 |
C-C chemokine receptor type 2 | 0 | 1 | 0 | 1 |
Cannabinoid receptor 2 | 0 | 0 | 1 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
ATP-binding cassette sub-family C member 8 | 0 | 2 | 0 | 2 |
ATP-sensitive inward rectifier potassium channel 11 | 0 | 2 | 0 | 2 |
Sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
Thrombin | 0 | 0 | 1 | 1 |
Met repressor | 0 | 0 | 2 | 2 |
Protein arginine N-methyltransferase 5 | 0 | 0 | 1 | 1 |
Histone H3K27 methylase | 0 | 0 | 0 | 1 |
Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 2 |
S-adenosylmethionine decarboxylase proenzyme | 0 | 1 | 0 | 2 |
Protein-L-isoaspartate(D-aspartate) O-methyltransferase | 0 | 1 | 0 | 1 |
Catechol O-methyltransferase | 0 | 0 | 0 | 1 |
Protein arginine N-methyltransferase 1 | 0 | 1 | 0 | 1 |
Methylosome protein 50 | 0 | 0 | 1 | 1 |
Chain A, Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Chain A, Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
pregnane X receptor | 1 | 0 | 0 | 1 |
activating transcription factor 6 | 2 | 0 | 0 | 2 |
Histone H2A.x | 2 | 0 | 0 | 2 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
Vpr | 1 | 0 | 0 | 1 |
Estrogen receptor | 0 | 2 | 1 | 3 |
Glucocorticoid receptor | 0 | 2 | 1 | 3 |
Progesterone receptor | 0 | 2 | 1 | 3 |
Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
Mineralocorticoid receptor | 0 | 2 | 0 | 3 |
Androgen receptor | 0 | 2 | 1 | 3 |
Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 1 | 1 | 2 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
UDP-glucuronosyltransferase 2B7 | 0 | 0 | 0 | 1 |
UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 1 |
Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
Peptidyl-prolyl cis-trans isomerase FKBP1A | 0 | 2 | 1 | 3 |
Peptidyl-prolyl cis-trans isomerase FKBP1B | 0 | 0 | 1 | 1 |
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
Peptidyl-prolyl cis-trans isomerase FKBP5 | 0 | 1 | 0 | 1 |
Splicing factor 3B subunit 3 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1B1 | 0 | 1 | 0 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 1 | 0 | 0 | 1 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
regulator of G-protein signaling 4 | 1 | 0 | 0 | 1 |
thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
vitamin D3 receptor isoform VDRA | 1 | 0 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
UDP-glucuronosyltransferase 1-6 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A1 | 0 | 0 | 0 | 1 |
Mitogen-activated protein kinase 1 | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
Forkhead box protein M1 | 0 | 2 | 0 | 2 |
Indoleamine 2,3-dioxygenase 2 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A10 | 0 | 0 | 0 | 1 |
Chain A, Trp Rna-binding Attenuation Protein | 0 | 0 | 1 | 1 |
Chain K, Trp Rna-binding Attenuation Protein | 0 | 0 | 1 | 1 |
Chain B, tryptophanyl-tRNA synthetase | 0 | 0 | 1 | 1 |
Chain C, Tryptophanyl-tRNA synthetase II | 0 | 0 | 1 | 1 |
thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
Myeloperoxidase | 0 | 1 | 0 | 1 |
Stromelysin-1 | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 2 |
Substance-P receptor | 0 | 1 | 0 | 1 |
Tryptophan 2,3-dioxygenase | 0 | 1 | 0 | 2 |
SLC16A10 protein | 0 | 0 | 0 | 1 |
Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 1 | 0 | 1 |
Tryprostatin B synthase | 0 | 0 | 0 | 1 |
2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase | 0 | 0 | 1 | 1 |
Monocarboxylate transporter 10 | 0 | 0 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |